Supply Chain

Managing supplies is a crucial part of moving medical products from the manufacturer to patient’s bedside. Efficient supply chains can reduce healthcare costs and make medical devices more affordable for patients and health systems. This news page includes content on supply shortages, inventory management, and procurement practices.

FTC seeks more time to settle insulin pricing lawsuit with remaining PBM defendants
The request to the court comes a month after the agency settled with Express Scripts, under the condition the company change its wholesale buying practices, pass on manufacturer rebates and support TrumpRx.gov. Now it's up to CVS Caremark and UnitedHealth’s Optum Rx to make deals of their own.
Two drug suppliers plead guilty in $50M ‘straw purchase’ resale scheme
The two men, Frank Incognito, 46, and Stephen Corba, 50, conspired with doctors in a scheme involving the fraudulent purchase of critical cancer and macular degeneration drugs, which were then diverted and resold for profit. The U.S. Department of Justice said the unlawful pact lasted seven years.
CMS defers $260M in Medicaid funds as part of ‘major crackdown on healthcare fraud’
The money was meant for Minnesota, where criminals were indicted for abusing the Medicaid system to run bogus daycare centers. The Centers for Medicare & Medicaid Services did not specify how the state can rectify the situation to the Trump administration’s satisfaction.
FDA announces recall on infusion systems after software anomaly injures 2 patients
The recall has been designated as the most serious, Class I, but the issue can be remedied with a software update. The affected devices are Ivenix Large Volume Pumps manufactured by Fresenius Kabi.
Walgreens cuts 628 jobs and closes distribution facility, alarming private equity watchdog
Sycamore Partners took over the struggling retail pharmacy chain roughly six months ago, and the Private Equity Stakeholder Project fears early staffing cuts and store closures could spell trouble for the long-term health of the newly restructured business.

FTC seeks more time to settle insulin pricing lawsuit with remaining PBM defendants

The request to the court comes a month after the agency settled with Express Scripts, under the condition the company change its wholesale buying practices, pass on manufacturer rebates and support TrumpRx.gov. Now it's up to CVS Caremark and UnitedHealth’s Optum Rx to make deals of their own.

Two drug suppliers plead guilty in $50M ‘straw purchase’ resale scheme

The two men, Frank Incognito, 46, and Stephen Corba, 50, conspired with doctors in a scheme involving the fraudulent purchase of critical cancer and macular degeneration drugs, which were then diverted and resold for profit. The U.S. Department of Justice said the unlawful pact lasted seven years.

CMS defers $260M in Medicaid funds as part of ‘major crackdown on healthcare fraud’

The money was meant for Minnesota, where criminals were indicted for abusing the Medicaid system to run bogus daycare centers. The Centers for Medicare & Medicaid Services did not specify how the state can rectify the situation to the Trump administration’s satisfaction.

FDA announces recall on infusion systems after software anomaly injures 2 patients

The recall has been designated as the most serious, Class I, but the issue can be remedied with a software update. The affected devices are Ivenix Large Volume Pumps manufactured by Fresenius Kabi.

Vintage neon drug sign at the Walgreens pharmacy on Canal Street in downtown New Orleans.

Walgreens cuts 628 jobs and closes distribution facility, alarming private equity watchdog

Sycamore Partners took over the struggling retail pharmacy chain roughly six months ago, and the Private Equity Stakeholder Project fears early staffing cuts and store closures could spell trouble for the long-term health of the newly restructured business.

With SCOTUS striking down ‘Liberation Day’ tariffs, Trump implements 15% tax on all imports

The U.S. Supreme Court ruled President Donald Trump’s sweeping global tariffs unconstitutional. The administration responded by imposing a 10% rate across the board, later hiked to 15%. That will remain in effect for 150 days and require an act of Congress to extend.

Moderna, FDA reach compromise to accelerate approval of mRNA flu vaccine

The dispute centered around the pharmaceutical company's request for the shot to be approved for those aged 65 and over, a demographic the FDA argued was not properly represented in a 40,000-person clinical study. The company has agreed to perform additional research after the shot goes to market, having appeased regulators with safety data.

Rosabella Moringa FDA recall supplement salmonella

FDA investigating outbreak of ‘extensively’ antibiotic resistant salmonella linked to supplement

Capsules of moringa tree leaf, branded as Rosabella, are being recalled after seven states report cases of the illness, with three patients saying they took the supplement. The company has issued an emergency recall.